论文信息 - RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients. - 字舞流文

RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients.

Brian J. Smith | R. Askeland | J. Mezhir | S. M. Reed | D. Quelle | V. Tompkins | J. Weydert | J. Hagen | Xuefeng Zhang | Bradley D. McDowell | A. Button | V. Muniz | Jussara Hagen